Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

NCT03587662 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Kidney Medullary Carcinoma
Metastatic Renal Cell Carcinoma
SMARCB1 Negative
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8

Interventions

DRUG: Doxorubicin
DRUG: Doxorubicin Hydrochloride
DRUG: Gemcitabine
DRUG: Gemcitabine Hydrochloride
DRUG: Ixazomib
DRUG: Ixazomib Citrate

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]